| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Pantoprazole or omeprazole (PPI)[1] | Proton pump inhibitor | Pantoprazole 40 mg or omeprazole 20–40 mg PO once daily 30–60 min before breakfast for 4–8 weeks; step down to lowest effective dose for maintenance | Per weight per paediatric guidelines | First-line for symptomatic GERD; once-daily 30 min pre-breakfast better than after meals |
| Vonoprazan[1] | Potassium-competitive acid blocker (P-CAB) | 10–20 mg PO once daily | — | Newer acid-suppressant; faster onset, longer duration than PPI; effective for severe oesophagitis and refractory GERD |
| Famotidine[1] | H2 receptor antagonist | 20–40 mg PO BD | 0.5 mg/kg BD | Add at bedtime in nocturnal symptoms despite daytime PPI; mild GERD alternative |
| Antacid (calcium carbonate or aluminium-magnesium hydroxide)[1] | Antacid | PRN for breakthrough symptoms | — | Symptom relief layer on top of PPI; not maintenance therapy |
Diagnosis and stepped management of GERD in adults — lifestyle plus PPI for typical symptoms; endoscopic evaluation for alarm features.